Dentsply Sirona Acquires Cleverdent Ltd

Posted on January 18, 2018

Dentsply Sirona today announced the definitive agreement to acquire Cleverdent Limited. Cleverdent Ltd. developed the ClasenUNO® an innovative fusion of a dental mirror and high volume evacuation (HVE) tip which perfectly complements Dentsply Sirona’s portfolio.

York/Salzburg, January 18, 2018. Dentsply Sirona is committed to its Mission of empowering dental professionals to provide better, safer, faster dental care through the combination best in class technologies and clinical education, sales support and customer service. With the addition of Cleverdent Ltd.to Dentsply Sirona, dental professionals will benefit from a more efficient workflow across multiple procedures.

ClasenUNO creates efficiency for clinicians performing two-handed dentistry and reduces the need for four-handed procedures by enabling assistants to complete other tasks. The benefit of indirect vision and illumination through the mirror combined with high volume evacuation (HVE) can be used across multiple wet and dry procedures, with preventive and restorative applications, including ultrasonic scaling and air polishing procedures.

“This product provides our customers with innovative technology and enhances Dentsply Sirona’s dental procedures to support more efficient clinical outcomes”, Mark Trimmer, Interim Group Vice President Global Preventives, commented.

Stephan Clasen, Cleverdent Ltd. owner and dentist, developed and patented ClasenUNO in collaboration with a team of technical, design and materials specialists. Since 1999 Stephan Clasen has been running his own dental practice in Münster, Germany, with main focus on endodontics, periodontics, function diagnostics and holistic dental medicine. ClasenUNO, a pioneering fusion of dental mirror and high volume evacuation (HVE) tip, was first introduced at the 2015 International Dental Show and successfully launched in the German, Holland and Italian markets. It has since expanded into France, Portugal, Switzerland and South Africa.

Combining innovation and appealing aesthetics, the device was given the 2016 iF Design Award in the Medicine/Healthcare category. For more than 60 years, the iF Design Award has been recognized around the world as a trademark for design excellence. More than 5,000 entrants from 53 countries applied for the esteemed seal of quality.

About Cleverdent:

Cleverdent is a British company with its headquarter in Münster, Germany. It was founded in 2004 by Dentist Stephan Clasen and Dr. Martin Kayser. Purpose of the company was the development and marketing of ClasenUNO, a device invented by Clasen. From the beginning Cleverdent has cooperated with engineers and specialists in the areas of moulding and mirror technology. Since 2009 Cleverdent has also engaged Heinz-Jürgen Gerdes, a design and marketing expert specialized in bringing innovative ideas to market success.

Oral Health America to Award First Program Champion Awards at 28th Annual Gala & Benefit

Posted on January 18, 2018

Oral Health America (OHA) will present two new awards at its 28th Annual Gala & Benefit on February 21, 2018 at the new Marriott Marquis Chicago (at McCormick Place). OHA will recognize two program partners with a Program Champion Award, which acknowledges OHA partners who have demonstrated leadership and a collective impact on the oral health of vulnerable children or older adults in their geographical community.

The Marshall University/West Virginia Oral Health Coalition will be awarded the Smiles Across America® Program Champion Award for their commitment to advancing the oral health of low-income children in West Virginia and their contributions to growing the OHA Webinar Series. A founding partner of Smiles Across America, which helps to address and educate children and their families on the importance of oral health care, Marshall University/West Virginia Oral Health Coalition has strengthened their commitment to children through the establishment of West Virginia Healthy Kids and Families.

“Since 2006, Marshall University/West Virginia Oral Health Coalition has partnered with OHA to provide service to nearly 100,000 under- and uninsured children in rural West Virginia,” said Beth Truett, President & CEO for Oral Health America. “In addition to being instrumental in Smiles Across America and supporting school-based and school-linked sealant programs, they have also partnered with us for our Webinar Series, providing Continuing Education Credits through Marshall University to oral health professionals, nurses and social workers, helping to increase attendance at our 20 annual Webinars from 30 to 150 attendees.”

The DuPage County Health Department (DCHD) will be awarded the Wisdom Tooth Project® Program Champion Award for their dedication to advancing the oral health of older adults. In partnership with the Wisdom Tooth Project, which strives to improve the lives of older adults, DCHD hygienists have conducted over 50 Tooth Wisdom®: Get Smart About Your Mouth workshops to more than 720 older adults. These workshops provide older adults with a sense of self-efficacy to care for their oral health, delivered in community settings where they naturally congregate.

“The DuPage County Health Department took the initiative to call sites throughout the county to increase the number of Tooth Wisdom workshops, identifying new venues,” said Ms. Truett. “In addition, one of their hygienists assisted in the screenings of older adults as part of the ‘Manchester Project’ we are conducting in association with the Colgate Palmolive Dental Health Unit in Manchester, U.K. The findings of this global study will be submitted to the U.S. Administration on Community Living for evidence-based designation, making Tooth Wisdom: Get Smart About Your Mouth the first nationally approved oral health course for older adult consumers.” 

The Program Champion Awards will be presented during the dinner at OHA’s annual gala which is recognized as the premier charity event kicking off the Chicago Midwinter Meeting. It will feature a cocktail reception, dinner and dancing, as well as a silent auction and raffles.

Tickets for OHA’s gala are currently on sale. For more information on the 28th Annual Gala & Benefit, visit oralhealthamerica.org/gala or contact David Perez, Corporate Sponsorship Manager, at david.perez@oralhealthamerica.org or 312-836-9900.

All proceeds from the event underwrite OHA's mission to connect communities with resources to improve access to care, increase health literacy and raise awareness about the importance of oral health's impact on overall health. OHA’s programs serving children and older adults are active in 47 states and one U.S. territory as a result of support received from this annual event. Please join Oral Health America and commit to making a difference in the oral health of all Americans, especially those most vulnerable.

 

Office-Based Dental Anesthesia Gaining Ground over Hospital-Based

Posted on January 17, 2018

Dentist anesthesiologists are a unique medical provider. Their training is related more closely to medical anesthesiologists than to dentists in that they do not receive clinical training in dental or oral surgery. During their three-year residency program, dentist anesthesiologists receive most of their training in a hospital-based setting, performing a minimum of 800 cases of general anesthesia, of which at least 125 must be performed on children younger than seven years of age. However, very little is known about the post-residency practice characteristics of dentist anesthesiologists.

Researchers from the Indiana University School of Dentistry in Indianapolis, Brigham and Women’s Hospital in Boston, and the University of California at San Diego recently published a study in the current issue of Anesthesia Progress that examines the procedural differences between dentist and physician anesthesiologists. Using two main dental databases, the National Anesthesia Clinical Outcomes Registry (NACOR) and the Society for Ambulatory Anesthesia Clinical Outcomes Registry (SCOR), for dental and oral surgery procedures, the researchers compared 7,133 office-based procedures performed by dentist anesthesiologists with 106,420 in-hospital procedures provided by physician anesthesiologists.

The information from the SCOR database focused on office-based settings, while NACOR included hospital-based. The data showed that in both groups children six years and younger were the predominant recipients receiving anesthetic dental treatment (two-thirds of NACOR patients; three-fourths of SCOR patients); however, the average age for SCOR was approximately nine years and for NACOR approximately 12 years. The researchers also found a 46 percent longer surgical time for the cases from the NACOR database versus those from the SCOR. Both databases noted that early childhood caries (tooth decay) was the main diagnosis for the dental procedures needing anesthesia.

In reviewing the data, the researchers found a clear correlation between early childhood caries and the need for anesthesia during dental procedures. Given that this is the most common disease among children six years and younger, with more than 4.5 million cases developing each year, pediatric dentists need dentist anesthesiologists. The researchers also found that the overall cost of pediatric dental procedures with anesthesia performed in a hospital-based setting has increased between three and four times than that of 20 years ago. Currently, an 84 percent cost savings is found when anesthesia is administered in an office-based setting.

Overall, there is a consistent trend with more dental anesthetic procedures being performed in an office-based setting, particularly for pediatric dentistry. The researchers have found that, “The anesthesia care provided by dentist anesthesiologists is also separate and distinct from anesthesia provided by oral and maxillofacial surgeons. Oral surgeons are the only other dentists who can legally administer general anesthesia; however, they receive approximately 6 months of general anesthesia training.  Dentist anesthesiologists provide care to younger patients for procedures of longer duration using an independent anesthesia provider model versus oral and maxillofacial surgeons who use the operator-anesthesia model for shorter procedures on older patients.”

More research in this field is necessary because the data collected from the SCOR and NACOR are fairly limited as to the amount of information that is collected from providers on a volunteer level. The researchers concluded that despite the limitations on data collection, they are confident that, “Office-based anesthesia rendered by dentist anesthesiologists is clearly a unique and efficient mode of anesthesia care for dentistry.” They also believe that the increasing trend in office-based procedures with dentist anesthesiologists will continue.

Full text of the article, “Comparison of Anesthesia for Dental/Oral Surgery by Office-based Dentist Anesthesiologists versus Operating Room-based Physician Anesthesiologists,” Anesthesia Progress, Vol. 64, No. 4, 2017, is now available here: http://www.anesthesiaprogress.org/doi/full/10.2344/anpr-65-01-04.

 

Donald M. Casey Jr. Appointed Chief Executive Officer of Dentsply Sirona

Posted on January 17, 2018

Dentsply Sirona, The Dental Solutions Company™, announced today that its Board of Directors has appointed Donald M. Casey Jr. as Chief Executive Officer and as a member of the Company’s Board of Directors, effective February 12, 2018. Mr. Casey succeeds Mark A. Thierer, who has served as Interim Chief Executive Officer since September 28, 2017. Mr. Thierer will continue to serve as Interim Chief Executive Officer through February 11, 2018, and will work closely with Mr. Casey to ensure a seamless transition.

“Dentsply Sirona’s Board of Directors is excited to appoint Don as our CEO,” said Eric K. Brandt, Non-Executive Chairman of the Board. “After a comprehensive search and careful consideration, our Board unanimously concluded that Don has the right mix of skills, experience, and talent to lead Dentsply Sirona to achieve its full potential. Don has deep experience in global manufacturing, product development, and distribution of medical devices and technology. Further, he has a strong track record of managing global healthcare businesses and partnering with healthcare professionals, which will be critical to Dentsply Sirona as we continue to execute our growth strategy, accelerate innovation, and advance dental care.”

"I would like to thank the Board of Directors for placing their trust and confidence in me,” stated Don Casey. “It is truly an honor to serve as the next Chief Executive Officer of Dentsply Sirona. This is a company that brings over a century of deep understanding of the market and its leading brands, an unparalleled track record for innovation, and a recognized commitment to clinical education. I firmly believe that Dentsply Sirona is well positioned to serve our customers by bringing comprehensive solutions globally. I look forward to working with the thousands of dedicated employees in driving growth in this attractive market and building on our position as the recognized market leader in the dental industry, empowering dental professionals to provide better, safer, and faster dental care worldwide."

Mr. Brandt added, "On behalf of the Dentsply Sirona Board of Directors, I would like to thank Mark Thierer for his outstanding service as Interim Chief Executive Officer. Under his leadership, the company made meaningful progress on a series of important initiatives, including the merger integration, advancing our operational objectives, and setting the company up for long term success and value creation. We appreciate Mark’s contributions and we wish him the best in his future endeavors.”

VITA Launches Zirconia Shade Liquids for Chairside Solutions

Posted on January 16, 2018

VITA North America, which pioneered the field of tooth shade determination with the development of the world-renowned VITA classical shade guide and its proprietary VITA SYSTEM 3D-MASTER®, introduces the VITA ZIRCONIA YZ HT SHADE LIQUIDs. Designed specifically for convenient chairside solutions, VITA ZIRCONIA YZ HT SHADE LIQUIDs deliver a perfect shade match each and every time. The new shade liquids eliminate the need to stock countless pre-shaded blocks that don’t match, while simultaneously streamlining chairside inventory. While the shade liquids were developed for use with VITA ZIRCONIA YZ material, they can also be used to infiltrate zirconia by other manufacturers, including pre-shaded zirconia blocks, which often don’t exactly match with their identified shade system.

Another convenient benefit: the ability to custom color zirconia restorations prior to sintering, while also creating fine shade tones quickly and easily. Colors can also be leveraged to adjust intensity and characterization. A complete range of shade options is available, including a combination of basic and additional shades that enable individual reproduction of the entire range of VITA shades. VITA ZIRCONIA YZ HT SHADE LIQUIDs are available in seven VITA classical A1-D4 shades and seven VITA SYSTEM 3D-MASTER shades, as well as supplementary shades for gingival, cervical and incisal areas.

VITA’s ZIRCONIA YZ HT SHADE LIQUIDs come in a convenient new starter kit, and contain all the essentials to deliver a perfect shade match and the highest level of esthetics for chairside and milling clinicians—all at an economical price. Plus, they’re easy to use! A few simple brush strokes following a “paint by numbers” technique is all it takes to deliver a finished restoration with natural esthetics.

VITA is a leading provider of innovative dental products. From premium denture teeth and veneering materials, to digital shade measurement, furnaces and CAD/CAM restorations, VITA helps laboratory technicians and clinicians deliver high quality and esthetic results to patients quickly and efficiently.

For more information, visit www.vitanorthamerica.com or call 800-828-3839.

 

Academy of Laser Dentistry Now Accepting Applications for 2018 Research Grants

Posted on January 11, 2018

The Academy of Laser Dentistry (ALD) the only independent and unbiased non-profit association dedicated to improving patient care with the proper use of laser technology, is now accepting applications for the Dr. Eugene M. Seidner Research Grants Program.

Named in the memory of Dr. Seidner, a laser dentistry pioneer who also served as ALD president 1996-1997, recipients will be honored during the ALD’s 25th Anniversary Conference & Exhibition, April 26-28th at the Caribe Royale Orlando, Florida.

According to ALD executive director Gail Siminovsky, CAE, “We established the scholarship in Dr. Seidner’s honor in 2004. In 2012, we reached our $100,000 fundraising goal, and now in 2018 ALD is excited to introduce research grants to the Seidner opportunities. The grant is intended to strengthen the Academy of Laser Dentistry’s mission of fostering a positive impact on dental laser education and research.” 

Research Grant Details

The Dr. Eugene M. Seidner Research Grant was founded to promote the advancement of dental laser technology education and clinical research. Up to three grant awards totaling up to $20,000.00 may be awarded annually to individuals to promote basic and applied clinical research for the use of lasers in dentistry.

To be considered, the project must broadly assess the role of lasers of dentistry, irrespective of whether the technology is used for surgical, diagnostic, antimicrobial, photo biomodulation, photodynamic therapy, imaging, or biomaterials applications. Research proposals on competing designs or devices are not encouraged.

Primary applicants or at least one team member must be member(s) of the Academy of Laser Dentistry for the past 3 years prior to application. Full details and applications may be downloaded or received by contacting the Academy of Laser Dentistry. Completed applications must be received by ALD by the end March 1, 2018 for consideration for the 2018 annual conference. Click here for complete details and to download an application.

Institutional Relationships

The award is made to the sponsoring academic institution on the behalf of the awardee. The institution must have the environment and general resources suitable for conducting research as stated in the application. What’s more, a letter of support from the dean or director of the institution must be enclosed with the application. The investigator is directly responsible to the sponsoring institution for the proper conduct of the project and management of the funds. Click here to download details and an application.

Donations Welcome

Voluntary donations from ALD members and others in the dental profession, have funded the Dr. Seidner Scholarship program and to date, 26 dental students from around the world have traveled to the ALD annual session to present their work and benefit from ALD membership, ALD conference attendance and in receiving Standard Proficiency Dental Laser Education and certification. Click heredownload more information and a contribution form.

About the Academy of Laser Dentistry

The Academy of Laser Dentistry (ALD) is the only independent and unbiased non-profit association devoted to laser dentistry and includes clinicians, academicians and researchers in all laser wavelengths. The Academy is devoted to clinical education, research, and the development of standards and guidelines for the safe and effective use of dental laser technology. ALD was founded in 1993, with the merging of the International Academy of Laser Dentistry, the North American Academy of Laser Dentistry and the American Academy of Laser Dentistry. For more information, visit www.LaserDentistry.org.

About ALD2018:

ALD’s upcoming annual meeting (ALD2018) promises to be the Academy’s biggest annual event to date. This year’s theme is “Innovation, Illumination, Imagination – Celebrating Laser Dentistry 25 Years and Beyond.” ALD2018 will take place from April 26-28th at the Caribe Royale Orlando, Florida. For more information and to register, visit http://www.laserdentistry.org/index.cfm/conference.

New Regional Sales Director Joins Panthera Dental

Posted on January 11, 2018

Panthera Dental is pleased to announce and welcome Jean-François Brault-Joubert as Regional Sales Director for Montreal and Outaouais. Jean-François will be responsible for these regions and will be taking care of existing clients, as well as developing new business opportunities and creating customized solutions for dental teams.

Jean-François has over 8 years of experience as a sales representative, 5 of which were spent in the dental field, where he has collaborated with a number of specialists, dentists, dental laboratories, and denturists. As such, he is focused on delivering outstanding service and commitment to his clients.

Jean-François Brault Joubert says, “It is with great enthusiasm that I now join Panthera Dental’s team. Since the company is in constant evolution, this will be a great opportunity for me to put my experience and passion to the test and be there for my clients as their new Regional Sales Director in Montreal and Outaouais.”

Restorative Dentistry Market Worth $25.9 Billion by 2025

Posted on January 11, 2018

The global restorative dentistry market is anticipated to reach $25.9 billion by 2025, growing at a CAGR 6.7%, according to a new report by Grand View Research, Inc. Among the key factors driving market growth are the growing number of dental practices with a shifting trend towards group and corporate dental practices; the advent of digital dentistry; an increasing demand for cosmetic dentistry and implants; and the growth of dental tourism.

With the growing enrollment of students into dental schools, the number of dental practices is likely to increase over the forecast period. The shifting trend towards group, multi-unit, and corporate dental practices which are focused on providing high-efficiency, quality care to patients is also likely to bolster the restorative dentistry market. Due to growing consumerism and disposable income amongst patients, the demand for cosmetic dentistry procedures focused on esthetics is also rising. These factors are in turn likely to boost the restorative dentistry market over the forecast period.

The advent of digital dentistry and technological advancements such as CAD/CAM systems, intraoral imaging, digital radiography, caries diagnosis, and computer-aided implant dentistry has improved the precision and accuracy of restorations. This has also contributed to the growth of the restorative dentistry market. The growth of dental tourism, especially in emerging economies such as India and China, is also likely to drive the restorative dentistry market over the forecast period, especially in Asia Pacific.

Sterngold Appoints New Director of Technical and Education

Posted on January 11, 2018

Sterngold has announced the addition of Robert Vasile to the Sterngold Dental team. Robert has been hired to fill the roll of Director of the Technical and Educational Department, effective January 2, 2018.

Robert brings with him a vast background of previous experience in dental lab ownership and management, product development, digital dentistry, education, and technical support. He most recently held the role of CAD/CAM and Laboratory Services Manager for Bicon and formerly served in management positions with both Sirona and Astra Tech Dental.

Bisphosphonates Shown to Affect Dental Implant Surgery

Posted on January 11, 2018

Postmenopausal women often suffer from osteoporosis, resulting in a loss of bone mass and strength. To combat this disease, many women take bisphosphonates (BPs), a group of medicines that help slow or prevent bone loss. However, BP therapy in terms of successful dental implantation has not been well documented. Dental implantation tends to be highly predicative in terms of effectiveness, but when medication is introduced that will change the overall landscape of the mandible (jawbone) structure, implant failure can be a side effect.

Researchers from the Kanagawa Dental University Hospital and the Tokyo Medical and Dental University have recently performed a study focused on the use of BP therapy and its effect on the quality of the mandible. The researchers evaluated the bone mineral density and cortical bone thickness (the outer layer bone thickness) of the mandible, as well as how long-term BP therapy effected early implant failure.

This study included 25 female patients, at least 60 years of age, with a previous osteoporosis diagnosis, and who underwent dental implant surgery in the mandible between January 2010 and March 2013. The patients were divided into two groups: (1) the BP group consisted of 11 patients who had been taking BPs for more than one year, and (2) the remaining 14 patients were in the non-BP group and had been prescribed a type of hormone therapy. The patients were compared using several computed tomography (CT) scans of their mandible to gauge bone mineral densities, cortical bone thickness, and the effect that the duration of BP therapy had on these two factors.

The researchers found that in the BP group, 11 patients with a total of 25 implants had three (11.1%) of those implants fail in three (25%) different patients within one year. In the non-BP group, the 14 patients had a total of 28 implants. Every implant in the non-BP group survived. It was also found that the BP group had a higher bone mineral density than the non-BP group, and those patients with a longer duration of BP therapy had increased cortical bone thickness. Overall, the researchers believe that BP use is correlated with increased bone mineral density and cortical bone thickness.

The researchers conclude that, “These results indicate that BPs affect the quality and quantity of the cortical bone in the partially edentulous posterior mandible of patients with osteoporosis, which should be considered prior to treatment with dental implants in patients taking BPs.”

This study was limited by both its small population size and the question of whether or not the medications used in the non-BP group had an effect on the mandible as well (which was not tested). However, the researchers have found that BP therapy does impact the mandible, and clinicians should be mindful that remodeling of the mandible could occur in patients receiving BP therapy, prior to beginning implant treatment.

Full text of the article, “Influence of Bisphosphonates on Implant Failure Rates and Characteristics of Postmenopausal Woman Mandibular Jawbone,” Journal of Oral Implantology, Vol. 43, No. 5, 2017, is available at: http://joionline.org/doi/full/10.1563/aaid-joi-D-17-00015

 

© 2018 AEGIS Communications | Privacy Policy